AllianceBernstein
IRMD icon

AllianceBernstein’s iRadimed IRMD Stock Holding History

AllianceBernstein’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.68M Buy
38,235
+17,663
+86% +$1.61M ﹤0.01% 1719
2026
Q1 		$2M Buy
20,572
+11,310
+122% +$1.13M ﹤0.01% 2008
2025
Q4 		$901K Hold
9,262
– – ﹤0.01% 2390
2025
Q3 		$659K Hold
9,262
– – ﹤0.01% 2540
2025
Q2 		$554K Sell
9,262
-1,000
-10% -$54.8K ﹤0.01% 2579
2025
Q1 		$539K Sell
10,262
-370
-3% -$20.8K ﹤0.01% 2523
2024
Q4 		$585K Sell
10,632
-698
-6% -$36.7K ﹤0.01% 2566
2024
Q3 		$570K Hold
11,330
– – ﹤0.01% 2601
2024
Q2 		$498K Buy
11,330
+450
+4% +$19.1K ﹤0.01% 2671
2024
Q1 		$479K Sell
10,880
-460
-4% -$20.3K ﹤0.01% 2600
2023
Q4 		$538K Sell
11,340
-1,250
-10% -$52.5K ﹤0.01% 2572
2023
Q3 		$559K Sell
12,590
-400
-3% -$18.6K ﹤0.01% 2517
2023
Q2 		$620K Sell
12,990
-310
-2% -$14K ﹤0.01% 2520
2023
Q1 		$523K Hold
13,300
– – ﹤0.01% 2550
2022
Q4 		$376K Buy
13,300
+600
+5% +$17.2K ﹤0.01% 2780
2022
Q3 		$382K Hold
12,700
– – ﹤0.01% 2764
2022
Q2 		$431K Buy
12,700
+400
+3% +$14.3K ﹤0.01% 2740
2022
Q1 		$552K Hold
12,300
– – ﹤0.01% 2632
2021
Q4 		$568K Hold
12,300
– – ﹤0.01% 2679
2021
Q3 		$413K Hold
12,300
– – ﹤0.01% 2832
2021
Q2 		$362K Buy
12,300
+200
+2% +$5.51K ﹤0.01% 2952
2021
Q1 		$312K Hold
12,100
– – ﹤0.01% 2888
2020
Q4 		$276K Hold
12,100
– – ﹤0.01% 2894
2020
Q3 		$259K Sell
12,100
-1,400
-10% -$31.4K ﹤0.01% 2870
2020
Q2 		$313K Buy
13,500
+3,600
+36% +$77.3K ﹤0.01% 2858
2020
Q1 		$211K Buy
+9,900
New +$236K ﹤0.01% 2782

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein's IRMD Position: Q2 2026 in Review

AllianceBernstein increased its iRadimed (IRMD) stake by 86% in Q2 2026, buying an estimated $1.61M and bringing the position to 38,235 shares worth $3.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1719.

AllianceBernstein first reported a position in IRMD in Q1 2020 and has held it in 26 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • AllianceBernstein held 38,235 shares of iRadimed worth $3.68M as of Q2 2026.
  • AllianceBernstein bought 17,663 iRadimed shares in Q2 2026, an estimated $1.61M.
  • iRadimed made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1719 holding.
  • AllianceBernstein first reported a position in iRadimed in Q1 2020 and has held it in 26 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.